Abstract
Polyether antibiotics (ionophores) represent a large group of lipophilic compounds which are able to form complexes with the metal cations and transport them across the lipid membranes. This process disturbs the intercellular Na+/K+ concentration gradient and intracellular pH and leads to the mitochondrial injuries, cell swelling, vacuolization and finally to apoptosis process. For this reason, ionophores are commonly used in veterinary medicine as the non-hormonal growth-promoting and coccidiostatic agents. In this group, particularly interesting are monensin and salinomycin because of their proved anti-tumour activity, including efficiency against multidrug-resistant cancer cells and cancer stem cells. Prompted by the idea that cancer cells may be individually effectively killed by these compounds, a very interesting direction of research is bioconjugation process of ionophores. This review is focused on the possible role of hybrids of ionophore antibiotics with other biologically active substances in anti-cancer and anti-bacterial treatment and gives an overview of their properties.
Keywords: Ionophore antibiotics, monensin, salinomycin, bioconjugation, hybrid compounds, anticancer activity, antibacterial activity.
Graphical Abstract
Mini-Reviews in Organic Chemistry
Title:Bioconjugation of Ionophore Antibiotics: A Way to Obtain Hybrids with Potent Biological Activity
Volume: 14 Issue: 4
Author(s): Michal Antoszczak*Adam Huczyński
Affiliation:
- Department of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznań,Poland
Keywords: Ionophore antibiotics, monensin, salinomycin, bioconjugation, hybrid compounds, anticancer activity, antibacterial activity.
Abstract: Polyether antibiotics (ionophores) represent a large group of lipophilic compounds which are able to form complexes with the metal cations and transport them across the lipid membranes. This process disturbs the intercellular Na+/K+ concentration gradient and intracellular pH and leads to the mitochondrial injuries, cell swelling, vacuolization and finally to apoptosis process. For this reason, ionophores are commonly used in veterinary medicine as the non-hormonal growth-promoting and coccidiostatic agents. In this group, particularly interesting are monensin and salinomycin because of their proved anti-tumour activity, including efficiency against multidrug-resistant cancer cells and cancer stem cells. Prompted by the idea that cancer cells may be individually effectively killed by these compounds, a very interesting direction of research is bioconjugation process of ionophores. This review is focused on the possible role of hybrids of ionophore antibiotics with other biologically active substances in anti-cancer and anti-bacterial treatment and gives an overview of their properties.
Export Options
About this article
Cite this article as:
Antoszczak Michal*, Huczyński Adam, Bioconjugation of Ionophore Antibiotics: A Way to Obtain Hybrids with Potent Biological Activity, Mini-Reviews in Organic Chemistry 2017; 14 (4) . https://dx.doi.org/10.2174/1570193X14666170518112608
DOI https://dx.doi.org/10.2174/1570193X14666170518112608 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
<i>DBX2</i> Promotes Glioblastoma Cell Proliferation by Regulating <i>REST</i>
Expression
Current Pharmaceutical Biotechnology Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment
Current Drug Targets Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
Current Cancer Drug Targets Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry The Role of the Endoplasmic Reticulum in the Accumulation of β-Amyloid Peptide in Alzheimers Disease
Current Molecular Medicine Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Summary of Information on the Effects of Ionizing and Non-ionizing Radiation on Cytochrome P450 and Other Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling
Current Pharmaceutical Design Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells
Current Stem Cell Research & Therapy PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update
Current Vascular Pharmacology Silibinin – A Promising New Treatment for Cancer
Anti-Cancer Agents in Medicinal Chemistry Peptide-Receptor Ligands and Multivalent Approach
Anti-Cancer Agents in Medicinal Chemistry Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Epigenetics in Brain Tumors: HDACs Take Center Stage
Current Neuropharmacology Heterocyclic Nucleosides: Chemical Synthesis and Biological Properties
Current Medicinal Chemistry Minocycline and Doxycycline: More Than Antibiotics
Current Molecular Pharmacology Endogenous Events Modulating Myogenic Regulation of Cerebrovascular Function
Current Vascular Pharmacology Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis
Current Pharmaceutical Design